{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:35:51Z","timestamp":1791052551046,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research and Graduate Studies, Khon Kaen University, Thailand"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Rapid skin thickness progression assessed using the modified Rodnan skin score (mRSS) is associated with poor outcomes in systemic sclerosis (SSc). However, the correlation between patterns of skin thickness and the onset of internal organ involvement remains unclear. This study aimed to determine the correlation between peak skin thickness progression rate (pSTPR) and the onset of internal organ involvement, particularly interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) among Thai SSc patients. Method: A prospective cohort study with retrospective analysis was conducted on adult SSc patients who experienced the onset of their first non-Raynaud phenomenon symptoms between January 2013 and December 2020 and had at least a 2-year follow-up. Patients with an overlap syndrome were excluded from this study. The pSTPR was calculated by dividing the peak of the mRSS by the duration of disease at the peak of the mRSS. Result: A total of 509 patients were included in this study. The majority of cases were female (351; 69.0%) and comprised diffuse cutaneous SSc subsets (353 cases; 69.4%). The respective mean age and median pSTPR was 48.2 \u00b1 11.6 years and 1.63 points\/year (interquartile range 0.5\u20134.4). The respective median durations of disease at the onset of significant ILD (&gt;20% extent), ILD, and mean duration of disease at the onset of PAH were 3.4 (Q1\u2013Q3 1.4\u20137.7), 5.4 (Q1\u2013Q3 2.4\u20139.2), and 8.0 \u00b1 4.9 years. pSTPR was negatively correlated with disease duration at the onset of significant ILD (Rho \u22120.509, p &lt; 0.001), ILD (Rho \u22120.480, p &lt; 0.001), PAH (Rho \u22120.372, p = 0.03), and disease duration from onset to death (Rho \u22120.367, p = 0.03) after adjusting for age, sex, and anti-topoisomerase I. Conclusion: SSc patients with a high skin thickness progression rate reaching the maximum point of mRSS were at risk of developing early ILD, PAH, and death. The pSTPR may be used to assess individuals at risk of experiencing early onset cardiopulmonary involvement in SSc.<\/jats:p>","DOI":"10.3390\/jcm14072281","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:35:28Z","timestamp":1743132928000},"page":"2281","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients"],"prefix":"10.3390","volume":"14","author":[{"given":"Piyanart","family":"Rujirawinitchai","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-4389","authenticated-orcid":false,"given":"Chingching","family":"Foocharoen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraphop","family":"Suwannaroj","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patnarin","family":"Pongkulkiat","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tippawan","family":"Onchan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"ref_1","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"v44","DOI":"10.1093\/rheumatology\/ken309","article-title":"Skin involvement in systemic sclerosis","volume":"47","author":"Foeldvari","year":"2008","journal-title":"Rheumatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/rheumatology\/31.7.457","article-title":"Reliability of skin involvement measures in scleroderma","volume":"31","author":"Brennan","year":"1992","journal-title":"Br. J. Rheumatol."},{"key":"ref_4","first-page":"1217","article-title":"Measurement of skin involvement in scleroderma","volume":"22","author":"Black","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_5","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3899\/jrheum.081057","article-title":"Clinical Correlates of Self-reported Physical Health Status in Systemic Sclerosis","volume":"36","author":"Hudson","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: A predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","article-title":"Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort","volume":"78","author":"Wu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s10067-023-06550-7","article-title":"Incidence and prevalence of systemic sclerosis in Thailand in year 2017\u20132020: A database from the Ministry of Public Health","volume":"42","author":"Foocharoen","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/1756-185X.13060","article-title":"Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais","volume":"20","author":"Foocharoen","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_11","unstructured":"Clements, P.J., and Medsger, J. (2004). Thomas Feghali-Bostwick, C. Cutaneous involvvement in systemic sclerosis. Systemic Sclerosis, Lippincott. [2nd ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/1756-185X.13859","article-title":"Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study","volume":"23","author":"Foocharoen","year":"2020","journal-title":"Int. J. Rheum. Diseases."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_14","first-page":"98","article-title":"Rapid skin thickness progression rate is associated with high incidence rate of cardiopulmonary complications in patients with early diffuse cutaneous systemic sclerosis: Inception cohort study","volume":"38","author":"Wangkaew","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/j.1756-185X.2012.01760.x","article-title":"Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients","volume":"15","author":"Foocharoen","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_17","first-page":"1082","article-title":"Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study","volume":"98","author":"Foocharoen","year":"2015","journal-title":"J. Med. Assoc. Thai."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s40674-016-0052-9","article-title":"Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment","volume":"2","author":"Young","year":"2016","journal-title":"Curr. Treatm Opt. Rheumatol."},{"key":"ref_20","first-page":"254","article-title":"Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan\u2019s Skin Score on Systemic Sclerosis","volume":"53","author":"Hikmat","year":"2021","journal-title":"Acta Med. Indones."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mulalin, K., Mahakkanukrauh, A., Suwannaroj, S., Pongkulkiat, P., Onchan, T., Kasa, S., and Foocharoen, C. (2024). Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61159-3"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1007\/s00018-021-03874-y","article-title":"Idiopathic pulmonary fibrosis and systemic sclerosis: Pathogenic mechanisms and therapeutic interventions","volume":"78","author":"Mattoo","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-019-1919-6","article-title":"Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: A retrospective observational study","volume":"21","author":"Matsuda","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","article-title":"Mechanisms of skin fibrosis in systemic sclerosis","volume":"37","author":"Jinnin","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005382-199203000-00005","article-title":"Pulmonary manifestations of scleroderma","volume":"7","author":"Arroliga","year":"1992","journal-title":"J. Thorac. Imaging."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226429","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Lescoat","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/annrheumdis-2012-202849","article-title":"The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis","volume":"73","author":"Cottrell","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00296-018-4156-4","article-title":"High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome","volume":"38","author":"Wannarong","year":"2018","journal-title":"Rheumatol. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.22747","article-title":"Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody","volume":"56","author":"Perera","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.37275\/ijr.v13i1.161","article-title":"The Relationship Between Modified Rodnan Skin Score (mRSS) with Pulmonal Hypertension and Lung Fibrosis in Systemic Sclerosis Patients","volume":"13","author":"Rohman","year":"2021","journal-title":"Indones. J. Rheumatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2281\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:02:51Z","timestamp":1760029371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcm14072281"],"URL":"https:\/\/doi.org\/10.3390\/jcm14072281","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}